These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
706 related items for PubMed ID: 18695259
21. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Van Poznak C, Estilo C. Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349 [Abstract] [Full Text] [Related]
22. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C. Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822 [Abstract] [Full Text] [Related]
23. [Bisphosphonates and osteonecrosis of the jaws]. Urade M. Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882 [Abstract] [Full Text] [Related]
25. Bisphosphonates and jaw osteonecrosis: the UAMS experience. Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC. Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866 [Abstract] [Full Text] [Related]
26. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC. J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404 [Abstract] [Full Text] [Related]
27. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788 [Abstract] [Full Text] [Related]
28. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY. Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405 [Abstract] [Full Text] [Related]
29. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients. Favia G, Pilolli GP, Maiorano E. J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275 [Abstract] [Full Text] [Related]
30. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121 [Abstract] [Full Text] [Related]
31. Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel. Miyazaki H, Nishimatsu H, Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Ishikawa A, Igawa Y, Hirano Y, Homma Y. BJU Int; 2012 Dec 01; 110(11 Pt B):E520-5. PubMed ID: 22578070 [Abstract] [Full Text] [Related]
32. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach. Tirelli G, Biasotto M, Chiandussi S, Dore F, De Nardi E, Di Lenarda R. Head Neck; 2009 Sep 01; 31(9):1249-54. PubMed ID: 19260132 [Abstract] [Full Text] [Related]
33. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Vescovi P, Merigo E, Manfredi M, Meleti M, Fornaini C, Bonanini M, Rocca JP, Nammour S. Photomed Laser Surg; 2008 Feb 01; 26(1):37-46. PubMed ID: 18248160 [Abstract] [Full Text] [Related]
34. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients. Friedrich RE, Blake FA. Anticancer Res; 2007 Feb 01; 27(4A):1841-5. PubMed ID: 17649782 [Abstract] [Full Text] [Related]
35. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid. Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A. Haematologica; 2006 Jul 01; 91(7):968-71. PubMed ID: 16757414 [Abstract] [Full Text] [Related]
36. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL. J Oral Maxillofac Surg; 2009 Sep 01; 67(9):1904-13. PubMed ID: 19686928 [Abstract] [Full Text] [Related]
37. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Ann N Y Acad Sci; 2011 Feb 01; 1218():47-54. PubMed ID: 20946574 [Abstract] [Full Text] [Related]
38. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Leite AF, Figueiredo PT, Melo NS, Acevedo AC, Cavalcanti MG, Paula LM, Paula AP, Guerra EN. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul 01; 102(1):14-21. PubMed ID: 16831667 [Abstract] [Full Text] [Related]
39. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. Ibrahim T, Barbanti F, Giorgio-Marrano G, Mercatali L, Ronconi S, Vicini C, Amadori D. Oncologist; 2008 Mar 01; 13(3):330-6. PubMed ID: 18378544 [Abstract] [Full Text] [Related]
40. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer. Van Poznak C. Cancer Invest; 2006 Feb 01; 24(1):110-2. PubMed ID: 16467002 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]